16 employees
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
2008
$23M
from 2 investors over 2 rounds
Shaperon raised $23M on October 20, 2020
Investors: Yuanta Investment Korea (유안타인베스트먼트) and Smilegate Investment